Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 15 studies | 69% ± 13% | |
oligodendrocyte precursor cell | 13 studies | 39% ± 9% | |
glutamatergic neuron | 12 studies | 55% ± 20% | |
GABAergic neuron | 11 studies | 54% ± 24% | |
neuron | 7 studies | 43% ± 12% | |
interneuron | 6 studies | 57% ± 22% | |
retina horizontal cell | 6 studies | 45% ± 14% | |
cardiac muscle cell | 5 studies | 25% ± 6% | |
astrocyte | 4 studies | 31% ± 19% | |
endothelial cell | 4 studies | 44% ± 17% | |
granule cell | 4 studies | 59% ± 16% | |
type I pneumocyte | 4 studies | 19% ± 4% | |
GABAergic interneuron | 3 studies | 55% ± 5% | |
microglial cell | 3 studies | 31% ± 11% | |
fibroblast | 3 studies | 24% ± 4% | |
mast cell | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 50% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 93% | 1975.30 | 229 / 245 | 98% | 226.01 | 492 / 502 |
brain | 100% | 1942.44 | 2640 / 2642 | 87% | 23.25 | 612 / 705 |
esophagus | 31% | 100.62 | 446 / 1445 | 1% | 1.67 | 2 / 183 |
skin | 24% | 187.73 | 437 / 1809 | 3% | 0.64 | 15 / 472 |
adrenal gland | 9% | 32.61 | 23 / 258 | 16% | 3.57 | 37 / 230 |
heart | 19% | 62.74 | 165 / 861 | 0% | 0 | 0 / 0 |
stomach | 17% | 50.78 | 61 / 359 | 0% | 0.05 | 1 / 286 |
bladder | 14% | 52.86 | 3 / 21 | 1% | 0.19 | 7 / 504 |
intestine | 15% | 35.30 | 142 / 966 | 1% | 0.05 | 3 / 527 |
breast | 9% | 22.67 | 41 / 459 | 0% | 0.01 | 1 / 1118 |
uterus | 0% | 0 | 0 / 170 | 7% | 0.59 | 31 / 459 |
blood vessel | 6% | 20.23 | 85 / 1335 | 0% | 0 | 0 / 0 |
ovary | 4% | 15.82 | 8 / 180 | 1% | 0.10 | 5 / 430 |
thymus | 2% | 4.57 | 14 / 653 | 3% | 0.57 | 20 / 605 |
adipose | 3% | 6.89 | 34 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.71 | 3 / 178 |
lung | 1% | 1.06 | 3 / 578 | 1% | 0.07 | 9 / 1155 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.08 | 9 / 901 |
muscle | 1% | 1.27 | 5 / 803 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.80 | 1 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 1 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0007275 | Biological process | multicellular organism development |
GO_0030154 | Biological process | cell differentiation |
GO_0045720 | Biological process | negative regulation of integrin biosynthetic process |
GO_0044319 | Biological process | wound healing, spreading of cells |
GO_0051497 | Biological process | negative regulation of stress fiber assembly |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | TMEFF2 |
Protein name | Alternative protein TMEFF2 Tomoregulin-2 (TR-2) (Hyperplastic polyposis protein 1) (Transmembrane protein with EGF-like and two follistatin-like domains) |
Synonyms | TENB2 HPP1 TPEF UNQ178/PRO204 |
Description | FUNCTION: May be a survival factor for hippocampal and mesencephalic neurons. The shedded form up-regulates cancer cell proliferation, probably by promoting ERK1/2 phosphorylation. . |
Accessions | L8E8R4 ENST00000272771.10 [Q9UIK5-1] Q9UIK5 ENST00000409056.3 [Q9UIK5-3] ENST00000392314.5 [Q9UIK5-2] |